Zhejiang Jinhua Conba Bio-pharm. Co., Ltd. (Jinxi) – FDA 483, Jan 10, 2025
Zhejiang Jinhua Conba Bio-pharm, Co., Ltd., an API manufacturer in Jinhua City, China, was cited for significant deficiencies during an FDA inspection. Observations included inadequate validation of analytical methods for drug substances, insufficient controls over computerized systems leading to potential data manipulation, and failure to ensure equipment cleanliness before use, with residue found after cleaning. These issues indicate a lack of robust quality control and data integrity practices.
- Inspection date
- January 10, 2025
- Product type
- drugs
ID · 2737ddfd-182b-4bef-9768-35f6c6f1c503
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.